12.87
-0.09 (-0.69%)
Previous Close | 12.96 |
Open | 13.20 |
Volume | 8,789,299 |
Avg. Volume (3M) | 10,127,219 |
Market Cap | 8,770,003,968 |
Price / Earnings (TTM) | 12.38 |
Price / Earnings (Forward) | 12.50 |
Price / Sales | 1.31 |
Price / Book | 1.44 |
52 Weeks Range | |
Earnings Date | 24 Jul 2025 - 28 Jul 2025 |
Profit Margin | 10.70% |
Operating Margin (TTM) | 8.21% |
Diluted EPS (TTM) | 1.04 |
Quarterly Revenue Growth (YOY) | -5.90% |
Quarterly Earnings Growth (YOY) | 6.80% |
Total Debt/Equity (MRQ) | 67.34% |
Current Ratio (MRQ) | 1.12 |
Operating Cash Flow (TTM) | 808.50 M |
Levered Free Cash Flow (TTM) | 751.08 M |
Return on Assets (TTM) | 3.53% |
Return on Equity (TTM) | 12.52% |
Market Trend
Short Term | Medium Term | ||
Industry | Medical Instruments & Supplies (US) | Bearish | Mixed |
Medical Instruments & Supplies (Global) | Bearish | Bearish | |
Stock | Avantor, Inc. | Bearish | Bearish |
AIStockmoo Score
Analyst Consensus | 1.0 |
Insider Activity | 3.5 |
Price Volatility | 4.0 |
Technical Moving Averages | 2.5 |
Technical Oscillators | -4.0 |
Average | 1.40 |
Avantor Inc provider of products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company has three geographic segments: the Americas, Europe, and AMEA. The company's product group consists of Equipment & instrumentation, Services & specialty procurement, Proprietary materials & consumables, and Third-party materials & consumables. Materials & consumables include high-purity chemicals and reagents, lab products and supplies, specialized formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, and education and microbiology and clinical trial kits, peristaltic pumps and fluid handling tips. |
|
Sector | Healthcare |
Industry | Medical Instruments & Supplies |
Investment Style | Mid Core |
% Held by Insiders | 1.22% |
% Held by Institutions | 103.36% |
Ownership
Name | Date | Shares Held |
---|---|---|
New Mountain Capital, L.L.C. | 31 Dec 2024 | 14,000,000 |
52 Weeks Range | ||
Price Target Range | ||
High | 22.00 (Wells Fargo, 70.94%) | Buy |
Median | 16.00 (24.32%) | |
Low | 14.00 (Goldman Sachs, 8.78%) | Hold |
14.00 (Stifel, 8.78%) | Hold | |
Average | 16.88 (31.16%) | |
Total | 4 Buy, 4 Hold | |
Avg. Price @ Call | 13.22 |
Firm | Date | Target Price | Call | Price @ Call |
---|---|---|---|---|
Goldman Sachs | 29 Apr 2025 | 14.00 (8.78%) | Hold | 12.69 |
Baird | 28 Apr 2025 | 17.00 (32.09%) | Buy | 12.49 |
Barclays | 28 Apr 2025 | 15.00 (16.55%) | Buy | 12.49 |
10 Apr 2025 | 18.00 (39.86%) | Buy | 14.70 | |
Morgan Stanley | 28 Apr 2025 | 15.00 (16.55%) | Hold | 12.49 |
RBC Capital | 28 Apr 2025 | 20.00 (55.40%) | Buy | 12.49 |
Stifel | 28 Apr 2025 | 14.00 (8.78%) | Hold | 12.49 |
Wells Fargo | 17 Apr 2025 | 22.00 (70.94%) | Buy | 15.10 |
Citigroup | 04 Mar 2025 | 18.00 (39.86%) | Hold | 15.50 |
Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
---|---|---|---|---|
ANDRES JUAN | 12.28 | - | 17,100 | 209,988 |
CARETHERS JOHN | 12.28 | - | 17,100 | 209,988 |
COUTURIER CHRISTOPHE | 12.02 | - | 61,074 | 734,109 |
ECK STEVEN W | 12.02 | - | 20,358 | 244,703 |
GOURDIER BENOIT | 12.02 | - | 162,866 | 1,957,649 |
HANKAMER BRITTANY | 12.02 | - | 122,149 | 1,468,231 |
JONES R. BRENT | 12.02 | - | 162,866 | 1,957,649 |
KANG LAN | 12.28 | - | 17,100 | 209,988 |
MAKIN LOUISE | 12.28 | - | 17,100 | 209,988 |
MASSARO JOSEPH R | 12.28 | - | 17,100 | 209,988 |
MURTHY MALA | 12.28 | - | 17,100 | 209,988 |
PEACOCK JONATHAN M | 12.28 | - | 17,100 | 209,988 |
SEVERINO MICHAEL | 12.28 | - | 17,100 | 209,988 |
SOKENU CLAUDIUS | 12.02 | - | 122,149 | 1,468,231 |
SUMME GREGORY L | 12.11 | - | 42,100 | 508,488 |
WALKER COREY | 12.02 | - | 162,866 | 1,957,649 |
Aggregate Net Quantity | 993,228 | |||
Aggregate Net Value ($) | 11,976,615 | |||
Aggregate Avg. Buy ($) | 12.15 | |||
Aggregate Avg. Sell ($) | - |
Name | Holder | Date | Type | Quantity | Price | Value ($) |
---|---|---|---|---|---|---|
GOURDIER BENOIT | Officer | 09 May 2025 | Acquired (+) | 162,866 | 12.02 | 1,957,649 |
JONES R. BRENT | Officer | 09 May 2025 | Acquired (+) | 162,866 | 12.02 | 1,957,649 |
COUTURIER CHRISTOPHE | Officer | 09 May 2025 | Acquired (+) | 61,074 | 12.02 | 734,109 |
HANKAMER BRITTANY | Officer | 09 May 2025 | Acquired (+) | 122,149 | 12.02 | 1,468,231 |
SOKENU CLAUDIUS | Officer | 09 May 2025 | Acquired (+) | 122,149 | 12.02 | 1,468,231 |
ECK STEVEN W | Officer | 09 May 2025 | Acquired (+) | 20,358 | 12.02 | 244,703 |
WALKER COREY | Officer | 09 May 2025 | Acquired (+) | 162,866 | 12.02 | 1,957,649 |
SEVERINO MICHAEL | Director | 08 May 2025 | Acquired (+) | 17,100 | 12.28 | 209,988 |
MAKIN LOUISE | Director | 08 May 2025 | Acquired (+) | 17,100 | 12.28 | 209,988 |
ANDRES JUAN | Director | 08 May 2025 | Acquired (+) | 17,100 | 12.28 | 209,988 |
MURTHY MALA | Director | 08 May 2025 | Acquired (+) | 17,100 | 12.28 | 209,988 |
KANG LAN | Director | 08 May 2025 | Acquired (+) | 17,100 | 12.28 | 209,988 |
PEACOCK JONATHAN M | Director | 08 May 2025 | Acquired (+) | 17,100 | 12.28 | 209,988 |
MASSARO JOSEPH R | Director | 08 May 2025 | Acquired (+) | 17,100 | 12.28 | 209,988 |
SUMME GREGORY L | Director | 08 May 2025 | Acquired (+) | 17,100 | 12.28 | 209,988 |
CARETHERS JOHN | Director | 08 May 2025 | Acquired (+) | 17,100 | 12.28 | 209,988 |
SUMME GREGORY L | Director | 07 May 2025 | Buy (+) | 25,000 | 11.94 | 298,500 |
Show more |
Date | Type | Details |
---|---|---|
16 May 2025 | Announcement | Avantor® to Participate in the 2025 RBC Capital Markets Global Healthcare Conference |
02 May 2025 | Announcement | Avantor® to Participate in Bank of America Securities 2025 Health Care Conference |
25 Apr 2025 | Announcement | Avantor® Announces CEO Transition |
25 Apr 2025 | Announcement | Avantor® Reports First Quarter 2025 Results |
01 Apr 2025 | Announcement | Avantor® Showcases Scalable Fluid Handling Innovations at INTERPHEX |
28 Mar 2025 | Announcement | Avantor® to Report First Quarter 2025 Earnings on Friday, April 25, 2025 |
17 Mar 2025 | Announcement | Avantor® Provides First Look at Recently Completed Hydration Expansion at DCAT Week 2025 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2025 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |